Tacrolimus/Sirolimus (T/S)-Based GvHD Prophylaxis Does Not Overcome Poor Outcome of HLA Mismatch after Unrelated Donor (URD) Peripheral Blood Stem Cell Transplantation

Monzr M. Al Malki(City of Hope), Ryotaro Nakamura(City Of Hope National Medical Center), Stephen J. Forman(City Of Hope National Medical Center), David Senitzer(City of Hope), Ketevan Gendzekhadze(City Of Hope National Medical Center), Anh Tuan Pham(City of Hope), Andy Dagis(City of Hope), Pablo Parker(City Of Hope National Medical Center), Joycelynne Palmer(City of Hope), Auayporn Nademanee(City Of Hope National Medical Center), Chatchada Karanes(Erasmus MC Cancer Institute)
Transplantation and Cellular Therapy
February 18, 2016
10.1016/j.bbmt.2015.11.958
Cited by 0

Related Papers

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
|Blood|2000|1.6k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse
|Journal of Clinical Oncology|2001|898